CLOs on the Move

Health Republic Insurance

www.healthrepublicny.org

 
Health Republic Insurance of New York is a not-for-profit health insurance CO-OP (Consumer Operated and Oriented Plan) established under the Affordable Care Act to expand affordable healthcare options for all New Yorkers. Our high-quality plans are available to individuals and small groups, both on exchange and off, throughout the state. Since we opened our doors in October of 2013, we`ve enrolled over 145,000 members, making us the largest health insurance cooperative in the country and one of the fastest growing insurance companies in New York history. Our tremendous success is a testament to the way our values resonate with our ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

higi

Higi began with a simple idea: being healthy should be simple, fun and rewarding. By making the process convenient and automated, we want to provide the most frictionless method for you to play an active role in your personal health and wellness. We are firm believers that understanding and tracking your data is the key first step to achieving your wellness goals. From your basic vitals to physical activity and nutrition, we are building solutions to help you do just that.

Adolescent AIDS Program

Adolescent AIDS Program is a Hastings, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Holy Redeemer Health System

Holy Redeemer Health System is committed to our mission to care, comfort and heal, and to providing excellent healthcare services to our community.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.